Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Development of novel therapeutics targeting the blood-brain barrier: from barrier to carrier
Key end points included: hospitalisation, heart failure (ICD-10-CM-I50), myocardial infarction (ICD-10-CM-I21), stroke and transient ischaemic attack (ICD-10-CM-I63, G45), development of diabetic microvascular complications (ICD-10-CM-E10.210.4) and all-cause mortality analysed 3 months to 5 years post drug initiation
GLP-1 medications can be genuinely life-changing
Individuals keen on using supplements as well as sunscreen
Independent pharmacies say this creates conflicts of interest that result in higher prescription costs and harms patient access to medicines by creating pharmacy deserts. In addition, these pharmacies say its difficult for them to ascertain their ultimate payments for drugs based on the contracts they receive from PBMs
